1910 Genetics is the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer. We are backed by leading investors including M12 - Microsoft's Venture Fund, Accenture Ventures, Playground Global, Sam Altman, Y Combinator, FoundersX Ventures, and Scientia Ventures.
| Website | https://1910genetics.com |
| Employees | 33 (6 on RocketReach) |
| Founded | 2018 |
| Address | 451 D Street Suite 905, Boston, Massachusetts 02210, US |
| Phone | +1 508-433-0126 |
| Technologies |
JavaScript
,
HTML
,
PHP
+25 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Drug Discovery, Biotechnology, Ai Platform, Multimodal Ai, Drug Development Technology, Laboratory Automation, Small Molecule Drugs, Pharmaceutical Research, Life Sciences, Pharmaceutical Technology, Computational Biology, Precision Medicine, Machine Learning, Data Streams, Bioinformatics, Genomics |
| Competitors | Ancestry, Invitae, MyHeritage, Fulgent Genetics, 23andMe, PathAI, Gene by Gene, Color, Genomenon, Inc, 2020 GeneSystems Inc. +31 more (view full list) |
Looking for a particular 1910 Genetics employee's phone or email?
Jen Asher is the Founder and CEO of 1910 Genetics.
6 people are employed at 1910 Genetics.
1910 Genetics is based in Boston, Massachusetts.